Trans-Arterial Micro-Perfusion (TAMP)

TAMP is an innovative platform technology for targeted delivery of chemotherapy for localized treatment of solid tumors in the peripheral system. With RenovoCath, a proprietary FDA cleared medical device system with dual-balloon infusion catheter, TAMP delivers intra-arterial chemotherapy directly to the tumor.

Learn more about the TAMP procedure in the video below.

Targeted Delivery

The therapeutic method of TAMP is specifically designed for the targeted delivery of chemotherapy through RenovoCath the peripheral vascular system. The proximal and distal occlusion balloons enable effective isolation of the vascular site to allow delivery of chemotherapy in a controlled environment.

Targeted Delivery Works*

Research using the therapeutic approach of RenovoRx’s TAMP procedure is promising. In one study, 73 percent of patients treated with TAMP found that patients with advanced pancreatic cancer who received chemotherapy via TAMP with RenovoRx’s platform had a survival rate of two years beyond their diagnosis.

*Rosemurgy AS et al. Delivery of Gemcitabine in Patients with Locally Advanced Pancreatic Adenocarcinoma. Journal of Pan Cancer 2017.

Caution: Federal (USA) law restricts this device to sale by or on the order of a physician.

The RenovoRx is cleared for chemotherapeutic drug infusion to selected sites in the peripheral vascular system. Prior to use, please refer to the RenovoRx IFU for complete product indications, warnings, precautions, contraindications, potential adverse effects and detailed instructions for use.